Regeneron drug approved to help prevent severe COVID in vulnerable after exposure
(HealthDay)—A preventive monoclonal antibody injection for people at high risk for developing severe COVID-19 after exposure to the coronavirus has been approved by the U.S. Food and Drug Administration.
Aug 4, 2021
1
110